WIRB-Copernicus Group Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Revenue & Financials

  • WIRB-Copernicus Group's revenue is currently $45M per year.
  • WIRB-Copernicus Group's revenue per employee is $186722

Employee Data

  • WIRB-Copernicus Group has 241 Employees.
  • WIRB-Copernicus Group grew their employee count by 16% last year.
  • WIRB-Copernicus Group currently has 66 job openings.

What Is WIRB-Copernicus Group?

WCG is the world's largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG's solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life. For more information, please visit www.wcgclinical.com.

keywords:Biotechnology,Healthcare,Pharmaceuticals

241

Number of Employees

$45M

Revenue (est)

66

Current Jobs

16%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TCP Reliable
$7.8M428%
TCP Reliable
$7.8M428%
Shionogi
$87M4698%
Trio, An FCB He...
$7.8M415%
Vertice Pharma
$7M4117%
Ortho Dermatolo...
$43.2M2297%
PRI Healthcare ...
$11.5M594%
TAIHO ONCOLOGY ...
$35.8M1949%
LEO Pharma Inc....
$42.4M2309%
Specialty Rx
$19.9M11213%

WIRB-Copernicus Group News

13-Mar-19 - Want Highly Qualified Sites? Follow These 6 Simple Rules

A report published by the WIRB-Copernicus Group (WCG) provides some insights. Titled “Six Practices of High Performing Clinical Research

31-Jan-19 - WIRB-Copernicus Group snaps up Velos eResearch for undisclosed

WIRB-Copernicus Group has boosted its clinical trial management solutions business as it adds CTMS specialist Velos eResearch to its

30-Jan-19 - WCG Acquires First Clinical Research, LLC

30, 2019 /PRNewswire/ -- The WIRB-Copernicus Group®'s (WCG™) Market Intelligence & Insights Division has acquired First Clinical

WIRB-Copernicus Group Funding

DateAmountRoundLead InvestorsReference
2017-05-10$3043295Article
2018-07-26$2604337Article

WIRB-Copernicus Group Executive Hires

DateNameTitleReference
2019-01-31Norman GoldfarbChief Collaboration OfficerArticle

WIRB-Copernicus Group Acquisitions

DateCompany NameAmountNotesReference
2016-03-10Clintrax Global, Inc.Article
2017-05-03ThreeWire IncArticle
2017-05-10MedAvante, IncArticle
2017-11-29Vigilare InternationalArticle
2018-03-28ACI ClinicalArticle
2018-07-26KMR Group, Inc.Article
2019-01-31Model Agreements & Guidelines InternationalArticle